Express News | Regen Biopharma, Inc. Expands Vision for Phase 1 Clinical Trial of Hemaxellerate™

BreakingsNov 20 05:05

REGEN BIOPHARMA INC To Carry Out 2-for-1 Stock Split On November 4th, 2024

October 17th (Eastern Time) - $REGEN BIOPHARMA INC(RGBP.US)$ is about to implement a 2-for-1 stock split of shares. The shares will begin trading on a split-adjusted basis from November 4th, 2024.$

Futu NewsOct 18 07:40

10-Q: Q3 2024 Earnings Report

SECAug 14 04:42 · Announcements

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on May 9, 2024

PR NewswireMay 8 02:44

Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now

Yahoo FinanceApr 3 19:00

Regen BioPharma, Inc. to Discuss Plans to Move Forward With HemaXellerate Into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024

PR NewswireApr 2 21:30